Patents for C12R 1 - Micro-organisms (92,025) |
---|
11/03/1992 | US5160735 Plasminogen activator |
11/03/1992 | US5160489 Expression vectors and method for their construction |
11/03/1992 | CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them |
11/03/1992 | CA1309683C Process for preparing l(-)-carnitine chloride from 3, 4-epoxybutyric esters and novel intermediate compounds |
11/03/1992 | CA1309680C Airlift insect cell culture |
11/03/1992 | CA1309679C Serum free media for the growth of insect cells and expression of products thereby |
11/03/1992 | CA1309678C Urease and method of producing the same |
11/03/1992 | CA1309675C Recombinant dna expression vectors and dna compounds that encode isopenicillin n synthetase from penicillium chrysogenum |
11/03/1992 | CA1309674C Signal peptide for the excretion of peptides in streptomycetes |
11/03/1992 | CA1309673C Recombinant dna expression vectors and dna compounds which encode isopenicillin n synthetase |
11/03/1992 | CA1309671C Monoclonal antibodies to cyclosporins |
11/03/1992 | CA1309670C Monoclonal antibodies to mucin-like human differentiation antigens |
11/03/1992 | CA1309613C Feed additive for animals, feed containing the said additive and process to enhance animal growth |
11/03/1992 | CA1309588C Method for cutting plant material |
11/02/1992 | WO1992019700A2 Continuous process for biocatalytic desulfurization of sulfur-bearing heterocyclic molecules |
11/02/1992 | CA2109091A1 Continuous process for biocatalytic desulfurization of sulfur-bearing heterocyclic molecules |
10/31/1992 | WO1992019751A1 Yeast promoter and use thereof |
10/31/1992 | CA2108966A1 Yeast promoter and its use |
10/30/1992 | WO1992020066A1 Head suspension assembly |
10/30/1992 | CA2109419A1 Head suspension assembly |
10/30/1992 | CA2067590A1 Multiple hepatitis b virus surface proteins which form particles |
10/30/1992 | CA2067405A1 Schizosaccharomyces-specific polypeptides |
10/30/1992 | CA2067290A1 Hepatitis b virus surface proteins with reduced host carbohydrate content |
10/30/1992 | CA2067003A1 Hbsag escape mutant vaccine |
10/30/1992 | CA2065716A1 Biotoxicity test for chemicals |
10/29/1992 | WO1992018627A1 Glial mitogenic factors, their preparation and use |
10/29/1992 | WO1992018624A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor |
10/29/1992 | WO1992018622A1 Novel proteases |
10/29/1992 | WO1992018614A1 Autoinducer |
10/29/1992 | WO1992018553A1 POLY-β-HYDROXY ALKANOATE (PHA) COPOLYMER, METHOD OF ITS PRODUCTION, THE MICROBE WHICH PRODUCES IT, AND PHA COPOLYMER BLEND |
10/29/1992 | WO1992018541A1 Dna encoding mammalian phosphodiesterases |
10/29/1992 | WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN |
10/29/1992 | WO1992016623A3 Receptors for bombesin-like peptides |
10/29/1992 | WO1992011370A3 Polypeptides derived from proteins of the hepatitis c virus |
10/29/1992 | WO1992006188A3 Thermostable dna polymerase |
10/29/1992 | DE4113385A1 Hybridtransposon mit pt-operon, plasmide und bakterienstaemme dafuer Hybrid transposon with pt-operon, plasmids and bakterienstaemme for it |
10/29/1992 | DE4111531A1 Plasmide zur fha-expression und wirte Plasmids for fha-expression and wirte |
10/29/1992 | CA2105395A1 Autoinducer |
10/28/1992 | EP0511011A1 Novel antibodies and methods for their use |
10/28/1992 | EP0511003A1 Superactive GRF analogs |
10/28/1992 | EP0510987A1 Dehalogenation of organohalogen-containing compounds |
10/28/1992 | EP0510904A1 Novel lipophilic macrolide useful as an immunosuppressant |
10/28/1992 | EP0510903A1 Novel lipophilic macrolide useful as an immunosuppressant |
10/28/1992 | EP0510878A1 Human neurokinin-1 receptor |
10/28/1992 | EP0510773A1 Canine coronavirus subunit vaccine |
10/28/1992 | EP0510712A2 Process for the separation of the optical isomers of alpha-substituted carboxylic acids |
10/28/1992 | EP0510693A2 Expression of human serum albumin in pichia pastoris |
10/28/1992 | EP0510678A2 Expression of human serum albumin in pichia pastoris |
10/28/1992 | EP0510673A2 Alkaline protease, method for producing the same, use thereof and microorganism producing the same |
10/28/1992 | EP0510662A1 bFGF mutein and its production |
10/28/1992 | EP0510658A2 Improvement of the secretion yield of proteins with a disulfide bridge |
10/28/1992 | EP0510319A2 Process for increasing the performance of L-lysine secreting coryneform microorganisms |
10/28/1992 | EP0510271A1 Novel R106 compounds |
10/28/1992 | EP0510186A1 Therapeutic uses of melanin |
10/28/1992 | EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof |
10/28/1992 | EP0510075A1 Human receptor of tsh. sequence coding for such receptor |
10/28/1992 | EP0504291A4 Novel proteins with oncostatin m activity and process for their preparation |
10/28/1992 | EP0243485B1 Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin |
10/28/1992 | CN1065729A Monoclonal antibodies |
10/28/1992 | CN1018846B Inosine preparing process by bacillus |
10/28/1992 | CN1018793B Homologues of aprotinin produced from recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof |
10/28/1992 | CA2067039A1 Neurotrophic peptide derivatives |
10/27/1992 | WO1992019373A1 Amoebae/bacteria consortia and uses for degrading wastes and contaminants |
10/27/1992 | US5159062 Fusion polypeptides |
10/27/1992 | US5159059 Process for reduction of certain cyclohexapeptide compounds |
10/27/1992 | US5158939 Administering a nontoxic lipopolysaccharide from rhodopseudomonas which negate the inhibitory effects of thymus derived T suppressor cells |
10/27/1992 | US5158937 Veterinary medicine |
10/27/1992 | US5158887 Process for massive conversion of clostridia in synchronized cells of elongated length or refractile endospores |
10/27/1992 | US5158886 Monoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereof |
10/27/1992 | US5158885 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes |
10/27/1992 | US5158878 Type ii restriction endonuclease swai |
10/27/1992 | US5158875 Production of biologically active insulin-like growth factor i from high expression host cell systems |
10/27/1992 | US5158788 Feed for aquaculture |
10/27/1992 | CA2067304A1 Superactive grf analogs |
10/27/1992 | CA2066992A1 Low-ash xanthan gum |
10/27/1992 | CA2066931A1 Bfgf mutein and its production |
10/27/1992 | CA2066926A1 Process for the separation of the optical isomers of alphasubstituted carboxylic acids |
10/27/1992 | CA2066556A1 Alkaline protease, method for producing the same, use thereof and microorganism producing the same |
10/24/1992 | CA2066499A1 Lipophilic macrolide useful as an immunosuppressant |
10/24/1992 | CA2066494A1 Lipophilic macrolide useful as an immunosuppressant |
10/21/1992 | EP0509834A2 Novel bacterial strain and method for producing theobromine using the same |
10/21/1992 | EP0509719A1 Compounds, vectors and methods for expressing human, cytosolic phospholipase A2 |
10/21/1992 | EP0509553A1 Anti-lymphotoxin antibody, its production and use |
10/21/1992 | EP0509056A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
10/21/1992 | EP0509008A1 Biomass for the production of viruses/virus antigens. |
10/21/1992 | EP0509006A1 Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
10/21/1992 | EP0508983A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
10/21/1992 | EP0481000A4 Receptors for fibroblast growth factors |
10/21/1992 | EP0191827B1 Method of removing n-terminal amino acid residues from eucaryotic polypetide analogs and polypeptides produced thereby |
10/21/1992 | CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom |
10/20/1992 | US5157112 Antibodies immunoreactive with the T-cell growth factor, P40 |
10/20/1992 | US5157110 Synthetic, anti-complement protein |
10/20/1992 | US5157106 N-terminal deletions of lymphotoxin, their preparation and use |
10/20/1992 | US5156977 Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use |
10/20/1992 | US5156966 Isolating from culture of Alcaligenes microorganism |
10/20/1992 | US5156961 Adhered to polymeri beads; treating with aqueous solution having specific gravity to separate |
10/20/1992 | US5156960 Microbial process for the production of immunosuppressive antibiotics |
10/20/1992 | US5156959 Introducing recombinant DNA construction into gramnegative bacteria, cultivating, recovering secreted proteins |
10/20/1992 | US5156958 Gene encoding a 30 kilodalton outer membrane protein of bordetella pertussis and method of recombinant production of said protein |
10/20/1992 | US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA |